OEV Partners exists to support and serve the emerging new industries, fresh thinking, and revolutionary mental health treatments now made possible by global drug law reform.
We believe that new treatments using psilocybin, MDMA, LSD, ibogaine and ketamine, will soon be as indispensable in mental healthcare as anaesthetic or antibiotics are in surgery – and so do increasing numbers of lawmakers, medics, and investors worldwide.
Our goal is to help uproot and rightly discard outdated policies and to help this dynamic and complex sector grow responsibly through research-based advocacy and campaigning, smart media consultancy, and original content creation. That means putting the needs of patients first – in everything we do, from advocacy and campaigning to education, continuous improvement and service design to ensure that services are designed with people at their heart and as many people as possible benefit as treatments and therapies come online.
What we do
Policy, Advocacy
and Campaigning
We create powerful narratives around areas of need that put lived experience at the centre, devising incisive policy that will deliver real change.
Research
and Data Analysis
Understanding is key, we use in-depth research and precise data analysis to provide compelling support for campaigns and policy.
Service Design
and Improvement
Real change means services designed with those with the need at the centre. We work with providers to ensure new services and treatments deliver enduring benefits.
Event Planning
and Management
We use in person and virtual events to inform, educate, and motivate and create and sustain a network of people and organisations driving change.